# A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)

> **NCT00592111** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 21 (actual)

## Conditions studied

- Pediatric
- Hodgkin's Disease

## Interventions

- **DRUG:** COPP/ABV
- **DRUG:** COPP/ABV
- **DRUG:** intensive chemo with concurrent growth factor

## Key facts

- **NCT ID:** NCT00592111
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-03
- **Primary completion:** 1999-02
- **Final completion:** 2008-01
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2015-12-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00592111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00592111, "A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00592111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*